XTL Biopharmaceuticals to Present at the 25th Annual JPMorgan Healthcare Conference
January 04 2007 - 3:51AM
PR Newswire (US)
NEW YORK, January 4 /PRNewswire-FirstCall/ -- XTL
Biopharmaceuticals Ltd. (NASDAQ:XTLB)(LSE:XTL)(TASE:XTL) announced
today that Ron Bentsur, the Company's Chief Executive Officer, is
scheduled to present at the 25th Annual JPMorgan Healthcare
Conference. Mr. Bentsur's presentation will take place on Thursday,
January 11, 2007 at 1:00 pm Pacific Standard Time (4:00pm Eastern
Standard Time) at the Westin St. Francis Hotel in San Francisco. A
live audio webcast of Mr. Bentsur's presentation will be available
at http://www.mapdigital.com/jpmorgan/healthcare07/. An archived
version of the webcast will be available following the conclusion
of the live presentation. About XTL Biopharmaceuticals Ltd. XTL
Biopharmaceuticals Ltd. ("XTL") is engaged in the acquisition,
development and commercialization of therapeutics for the treatment
of infectious diseases, with a focus on hepatitis C. XTL is
developing XTL-2125 - a small molecule, non-nucleoside inhibitor of
the hepatitis C virus polymerase. XTL-2125 is currently in a Phase
1 clinical trial in patients with chronic hepatitis C. XTL is also
developing XTL-6865 - a combination of two monoclonal antibodies
against the hepatitis C virus - presently in Phase 1 clinical
trials in patients with chronic hepatitis C. XTL's hepatitis C
pipeline also includes several families of pre-clinical hepatitis C
small molecule inhibitors. XTL also has an active in-licensing and
acquisition program designed to identify and acquire additional
drug candidates. XTL is publicly traded on the NASDAQ, London, and
Tel-Aviv Stock Exchanges (NASDAQ: XTLB)(LSE:XTL)(TASE:XTL).
Contact: Ron Bentsur, Chief Executive Officer Tel:
+1-(212)-531-5960 DATASOURCE: XTL Biopharmaceuticals Ltd CONTACT:
Contact: Ron Bentsur, Chief Executive Officer, Tel:
+1-(212)-531-5960
Copyright
XTL Biopharmaceuticals (NASDAQ:XTLB)
Historical Stock Chart
From Jun 2024 to Jul 2024
XTL Biopharmaceuticals (NASDAQ:XTLB)
Historical Stock Chart
From Jul 2023 to Jul 2024